Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eriksson

Showing results (681-690 of 838) with videos related to

Pageof 84
Sort By:
The British Journal of Surgery|September 28, 2021
Author response to: Risk factors and outcomes of chronic opioid use following traumaE von Oelreich, M Eriksson, O Brattström, et al.
Scandinavian Journal of Gastroenterology|September 1, 1985
Hydrogen concentration in expired air analyzed with a new hydrogen sensor, plasma glucose rise, and symptoms of lactose intolerance after oral administration of 100 gram lactoseA Berg, M Eriksson, F Bárány, et al.
International Journal of Obesity (2005)|February 24, 2011
Abdominal and gynoid adiposity and the risk of strokeF Toss, P Wiklund, P W Franks, et al.
Acta Medica Scandinavica|January 1, 1982
The effect of D,L-carnitine supplementation on muscle metabolism, neuropathy, cardiac and hepatic function in hemodialysis patients. A pilot studyB Fagher, H Thysell, P Nilsson-Ehle, et al.
Globalization and Health|August 17, 2018
A feasibility study of a mobile phone supported family-centred ADL intervention, F@ce™, after stroke in UgandaJulius T Kamwesiga, Gunilla M Eriksson, Kerstin Tham, et al.
Thrombosis Research|October 24, 2001
Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor proteinS He, H Cao, C G Magnusson, et al.
Journal of Internal Medicine|February 1, 1993
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapyL Berglund, O Wiklund, G Eggertsen, et al.
Journal of Internal Medicine|December 17, 2010
Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986-2009M Eriksson, L Holmgren, U Janlert, et al.
The Journal of Hospital Infection|April 3, 2010
Hospital outbreak control requires joint efforts from hospital management, microbiology and infection controlU Ransjö, B Lytsy, A Melhus, et al.
Neuropharmacology|July 18, 2009
Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activitiesJiun Youn, Ilga Misane, Therese M Eriksson, et al.
Pageof 84

Showing results (681-690 of 838) with videos related to

Sort By:
Pageof 84
The British Journal of Surgery|September 28, 2021
Author response to: Risk factors and outcomes of chronic opioid use following traumaE von Oelreich, M Eriksson, O Brattström, et al.
Scandinavian Journal of Gastroenterology|September 1, 1985
Hydrogen concentration in expired air analyzed with a new hydrogen sensor, plasma glucose rise, and symptoms of lactose intolerance after oral administration of 100 gram lactoseA Berg, M Eriksson, F Bárány, et al.
International Journal of Obesity (2005)|February 24, 2011
Abdominal and gynoid adiposity and the risk of strokeF Toss, P Wiklund, P W Franks, et al.
Acta Medica Scandinavica|January 1, 1982
The effect of D,L-carnitine supplementation on muscle metabolism, neuropathy, cardiac and hepatic function in hemodialysis patients. A pilot studyB Fagher, H Thysell, P Nilsson-Ehle, et al.
Globalization and Health|August 17, 2018
A feasibility study of a mobile phone supported family-centred ADL intervention, F@ce™, after stroke in UgandaJulius T Kamwesiga, Gunilla M Eriksson, Kerstin Tham, et al.
Thrombosis Research|October 24, 2001
Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor proteinS He, H Cao, C G Magnusson, et al.
Journal of Internal Medicine|February 1, 1993
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapyL Berglund, O Wiklund, G Eggertsen, et al.
Journal of Internal Medicine|December 17, 2010
Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986-2009M Eriksson, L Holmgren, U Janlert, et al.
The Journal of Hospital Infection|April 3, 2010
Hospital outbreak control requires joint efforts from hospital management, microbiology and infection controlU Ransjö, B Lytsy, A Melhus, et al.
Neuropharmacology|July 18, 2009
Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activitiesJiun Youn, Ilga Misane, Therese M Eriksson, et al.
Pageof 84